Long COVID and cardiovascular disease: a prospective cohort study.
Journal article
Lawson CA. et al, (2024), Open Heart, 11
The complexity of cardiovascular long COVID: where we are.
Journal article
Gandhi RS. and Raman B., (2024), Cardiovasc Res
Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.
Journal article
McCracken C. et al, (2024), BMJ Evid Based Med
Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
Journal article
Coleman JA. et al, (2024), Cardiovasc Res
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.
Journal article
Liew F. et al, (2024), Nat Immunol, 25, 607 - 621
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.
Journal article
Devine K. et al, (2024), Clin Endocrinol (Oxf), 100, 317 - 327
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Journal article
Maron MS. et al, (2024), J Am Coll Cardiol
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Journal article
Elneima O. et al, (2024), International Journal of Epidemiology, 53
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy.
Journal article
Coleman JA. et al, (2024), Comput Biol Med, 169
Photon-Counting Computed Tomography: "One-Stop Shop" For Coronary Stenosis, Inflammation And Myocardial Assessment in STEACS.
Journal article
Kotronias RA. et al, (2024), Eur Heart J Cardiovasc Imaging
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy.
Journal article
Coleman JA. et al, (2024), Front Pharmacol, 15
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Journal article
Taquet M. et al, (2024), Brain Commun, 6
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review.
Journal article
Singh SJ. et al, (2023), Eur Respir Rev, 32
Synbiotics in post-acute COVID-19 syndrome-a potential new treatment framework?
Journal article
Raman B. and Ramasamy MN., (2023), Lancet Infect Dis
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Journal article
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Journal article
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
Personalizing Apical Hypertrophic Cardiomyopathy Diagnosis: A Major Step Forward, but Challenges Remain.
Journal article
Raman B., (2023), JACC Cardiovasc Imaging
Erratum for: Lung Abnormalities Detected with Hyperpolarized 129Xe MRI in Patients with Long COVID.
Journal article
Grist JT. et al, (2023), Radiology, 309
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Journal article
Taquet M. et al, (2023), Nat Med
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Journal article
Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684